Literature DB >> 18560796

Stroke due to atrial fibrillation and the attitude to prescribing anticoagulant prevention in Italy. A prospective study of a consecutive stroke population admitted to a comprehensive stroke unit.

C Gandolfo1, M Balestrino, A Burrone, M Del Sette, C Finocchi.   

Abstract

BACKGROUND: Several studies have reported that oral anticoagulant prophylaxis (OAC) is under-used in patients with atrial fibrillation (AF).
OBJECTIVE: This study investigated the attitude to prescribing OAC in patients with AF observed in an Italian Stroke Unit (SU) and the severity of ischemic stroke due to AF in comparison with that of other etiologies.
METHODS: We prospectively studied a continuous series of acute stroke patients admitted to our SU from January 1, 2003 to December 31, 2005. Using Multiple Logistic Regression, we analyzed factors associated with the non-use of OAC and with poor prognosis.
RESULTS: Of 400 consecutive ischemic stroke patients, 103 (25.75 %) had AF; this group was older (mean age+/-sd= 79.74 +/- 10.15 years vs. 73.49 +/- 12.72; P = 0.0000045) and their strokes were more severe (NIHSS median value = 10 vs. 7, P < 0.002) in comparison with the group of patients whose strokes were due to other etiologies. Only 27.27% of patients with known AF, and without contraindications, were under OAC before the onset of stroke. The main independent factor associated with the non-use of OAC was old age. Moreover, AF proved to be a significant independent predictor of poor prognosis in our stroke population.
CONCLUSIONS: The results of this study indicate a marked under- use of OAC prophylaxis in AF subjects in Italy. Campaigns to raise awareness and to improve the implementation of guidelines on stroke prevention strategies are strongly recommended, not least because stroke due to AF has a worse prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560796     DOI: 10.1007/s00415-008-0615-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  42 in total

1.  Cerebral vascular accidents in patients over the age of 60. II. Prognosis.

Authors:  J RANKIN
Journal:  Scott Med J       Date:  1957-05       Impact factor: 0.729

Review 2.  Stroke incidence and prevalence in Europe: a review of available data.

Authors:  T Truelsen; B Piechowski-Jóźwiak; R Bonita; C Mathers; J Bogousslavsky; G Boysen
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

3.  Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).

Authors:  Kamakshi Lakshminarayan; Craig A Solid; Allan J Collins; David C Anderson; Charles A Herzog
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

4.  Warfarin use among patients with atrial fibrillation.

Authors:  L M Brass; H M Krumholz; J M Scinto; M Radford
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

5.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

6.  Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation.

Authors:  B F Gage; M Boechler; A L Doggette; G Fortune; G C Flaker; M W Rich; M J Radford
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

7.  Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

Authors:  G W Albers; J M Yim; K M Belew; N Bittar; C R Hattemer; B G Phillips; S Kemp; E A Hall; D J Morton; P H Vlasses
Journal:  Arch Intern Med       Date:  1996-11-11

8.  Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge.

Authors:  Dominique Deplanque; Didier Leys; Lucilla Parnetti; Reinhold Schmidt; Jose Ferro; Jacques de Reuck; Jean-Louis Mas; Virgilio Gallai
Journal:  Cerebrovasc Dis       Date:  2006-02-15       Impact factor: 2.762

9.  Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation.

Authors:  Elaine M Hylek; James D'Antonio; Carmella Evans-Molina; Carol Shea; Lori E Henault; Susan Regan
Journal:  Stroke       Date:  2006-03-09       Impact factor: 7.914

10.  Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men.

Authors:  Jaume Roquer; Ana Rodríguez-Campello; Meritxell Gomis; Angle Ois; José Enrique Martínez-Rodríguez; Elvira Munteis; Jordi Jiménez Conde; Joan Montaner; José Alvarez Sabín
Journal:  J Neurol       Date:  2006-08-28       Impact factor: 4.849

View more
  4 in total

1.  Validation of a simple method for atrial fibrillation screening in patients with stroke.

Authors:  C Gandolfo; M Balestrino; C Bruno; C Finocchi; N Reale
Journal:  Neurol Sci       Date:  2015-04-30       Impact factor: 3.307

2.  Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.

Authors:  Marzieh Balaghi-Inalou; Saeed Alipour Parsa; Latif Gachkar; Sasan Andalib
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-10-26

3.  Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices.

Authors:  Edward Ewen; Zugui Zhang; Teresa A Simon; Paul Kolm; Xianchen Liu; William S Weintraub
Journal:  Vasc Health Risk Manag       Date:  2012-10-19

4.  Adherence to Guidelines for Antithrombotic Therapy in Patients with Atrial Fibrillation According to CHADS2 Score before and after Stroke: A Multicenter Observational Study from Korea.

Authors:  Wook Joo Kim; Jong Moo Park; Kyusik Kang; Yong Jin Cho; Keun Sik Hong; Soo Joo Lee; Youngchai Ko; Kyung Bok Lee; Tai Hwan Park; Jun Lee; Jae Kwan Cha; Dae Hyun Kim; Kyung Ho Yu; Byung Chul Lee; Mi Sun Oh; Juneyoung Lee; Jisung Lee; Myung Suk Jang; Moon Ku Han; Hee Joon Bae
Journal:  J Clin Neurol       Date:  2015-11-04       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.